Skip to content

Clinical Utility of Intraoperative Parathyroid Scores System in Thyroidectomy

Clinical Utility of Intraoperative Parathyroid Scores System in Thyroidectomy

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03172312
Acronym
IPSS
Enrollment
500
Registered
2017-06-01
Start date
2014-01-01
Completion date
2016-12-31
Last updated
2017-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intraoperative Parathyroid Scores System

Keywords

Intraoperative Parathyroid Scores System, total thyroidectomy, thyroid cancer, hypoparathyroidism, prediction

Brief summary

Ready to establish the Intraoperative Parathyroid Scores System (IPSS) for thyroidectomy and study the clinical value of Intraoperative Parathyroid Scores System for thyroidectomy.

Detailed description

IPSS includes transplantation Parathyroid Scores and in situ Parathyroid Scores, the investigators will establish the Intraoperative Parathyroid Scores System by parathyroid size and Blood supply, and recording IPSS, according to certain rules. Parathyroid hormone and calcium were test in d0, d1, d14, d60 post operation. The correlation between Intraoperative Parathyroid Scores and PTH calcium were calculated, and ROC curve and logistic regression were tested for the prediction value.

Interventions

PROCEDUREDifferent range of thyroid surgery

Observe and record parathyroid status during thyroid surgery

Sponsors

Fujian Medical University
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
No minimum to 60 Years
Healthy volunteers
No

Inclusion criteria

1. postoperative pathology confirmed as thyroid papillary carcinoma; 2. for the first time to undergo thyroid surgery, no history of neck surgery and external radiotherapy; 3. preoperative serum calcium, parathyroid hormone levels were normal; 4. intraoperative and postoperative clinical data integrity, standardized follow-up patients; 5. parathyroid is a tumor violation.

Exclusion criteria

1. serious underlying disease; 2. age greater than 60 years of age or combined with arteriosclerotic disease; 3. patients with postoperative loss; 4. patients with parathyroid disease.

Design outcomes

Primary

MeasureTime frameDescription
transplantation Parathyroid Scores correlated with transplanted parathyroid function2014-2016relation with transplantation Parathyroid Scores and transplanted parathyroid hormone
the value of IPSS and in situ Parathyroid Scores2014-2016relation with Intraoperative Parathyroid Scores and in situ Parathyroid Scores
predicted function of IPSS2014-2016IPSS and in suit PSS be recoded and D1,D14 PTH Ca2+ were tested
value of IPSS in low PTH patients2014-2016IPSS and in suit PSS be recoded and D1,D14 PTH Ca2+ were tested

Secondary

MeasureTime frameDescription
value of IPSS for Surgeon and patient2014-2016description the clinic value

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026